Got $3,000? Here Are My Top 3 Artificial Intelligence (AI) Stocks to Buy Right Now

The article is bullish on three AI-related stocks: Microsoft, Nvidia, and Nebius, arguing they trade at attractive valuations relative to their growth prospects. Microsoft is said to be down about 30% from its high and valued at 19x forward earnings, while Nvidia trades at 23x forward earnings, or 16x next year’s estimates. Nebius is highlighted as the highest-growth idea, with revenue up 684% in Q1 and projected annual recurring revenue rising from $1.25B to $7B-$9B by end-2026.

Analysis

The key market mistake is treating AI infrastructure as a monolith. The beneficiaries are diverging: hyperscale software/platform owners with operating leverage and balance-sheet optionality are compounding differently than pure-play capacity providers, whose upside is increasingly tied to execution speed and financing terms. That means MSFT can re-rate on earnings durability even if AI capex normalizes, while NBIS remains a higher-beta claim on the supply bottleneck itself.

The second-order issue is that the market may be underestimating how quickly incremental supply commoditizes. If GPU availability improves faster than end-demand monetization, pricing power can leak from neoclouds to the largest distribution layers, compressing spreads for smaller operators. In that scenario, NVDA still wins, but the marginal beneficiary shifts from scarcity premium to installation-base expansion, which is typically less linear than the current narrative implies.

The contrarian read is that MSFT may be the best risk-adjusted expression here, not NBIS. A lower multiple on durable AI attach rates plus cloud growth gives you a cleaner path to multiple support if the AI trade cools, whereas NBIS already prices in a very aggressive scaling path and is vulnerable to any delay in capacity buildout, customer concentration, or funding-market tightening. The more crowded consensus trade is chasing the highest growth rate; the less crowded one is owning the operating-system layer that monetizes the whole stack.

Catalyst-wise, the next 1-3 quarters matter more for NBIS, while NVDA and MSFT can work over 12-24 months. The near-term risk is a capex digestion phase or a deceleration in enterprise AI adoption that forces investors to distinguish between bookings growth and cash earnings. If that happens, high-duration names likely de-rate first, and the best relative long becomes the one with the strongest free-cash-flow visibility.

Key Decisions for Investors

• Long MSFT / short NBIS as a quality-vs-scarcity pair trade for the next 3-6 months: own the AI monetization layer with lower execution risk, fade the highest-multiple capacity story if buildout slips even modestly.
• Add to NVDA on 10-15% pullbacks over a 6-12 month horizon; use it as the cleanest levered expression to continued AI capex, but size below MSFT because the stock is more exposed to any multi-quarter digestion in hyperscaler spend.
• For tactical upside, buy NBIS call spreads 6-9 months out only on weakness after confirmation of capacity milestones; the reward is high if the ARR ramp holds, but the position should be capped because financing and execution risk can reprice the equity quickly.
• If already long the basket, rotate 25-30% of capital from NBIS into MSFT to reduce drawdown risk while preserving AI exposure; this improves expected Sharpe if the market stops paying for growth at any price.
• Use NVDA as a hedge against underowned capex acceleration rather than a pure momentum trade; if hyperscaler spend re-accelerates, NVDA should outperform the rest of the AI complex by the widest margin.